146 related articles for article (PubMed ID: 34520844)
1. One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review.
Acheson LS; Siefried KJ; Clifford B; Murray E; Steele M; Clague L; Malone V; Roberts DM; Ferguson LJ; Matthews GV; Ezard N
Int J Infect Dis; 2021 Nov; 112():63-65. PubMed ID: 34520844
[TBL] [Abstract][Full Text] [Related]
2. Community-Acquired Staphylococcus aureus Bacteremia Among People Who Inject Drugs: A National Cohort Study in England, 2017-2020.
McGuire E; Collin SM; Brown CS; Saito M
Clin Infect Dis; 2024 Jun; 78(6):1443-1450. PubMed ID: 38315893
[TBL] [Abstract][Full Text] [Related]
3. Significantly lower 30 day/inpatient mortality observed in people who inject drugs (PWID) compared to non-PWID with Staphylococcus aureus bacteraemia.
Mortimer I; Drury K; Lowe S; Akhtar M; Barlow GD; Easom N; Lillie PJ
J Infect; 2022 Oct; 85(4):436-480. PubMed ID: 35724756
[No Abstract] [Full Text] [Related]
4. Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs - a single Centre retrospective cohort study in Denmark.
Thønnings S; Jansåker F; Sundqvist C; Thudium RF; Nielsen SD; Knudsen JD
BMC Infect Dis; 2020 Aug; 20(1):634. PubMed ID: 32847528
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs.
Wildenthal JA; Atkinson A; Lewis S; Sayood S; Nolan NS; Cabrera NL; Marschall J; Durkin MJ; Marks LR
Clin Infect Dis; 2023 Feb; 76(3):487-496. PubMed ID: 36052413
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review.
Asgeirsson H; Thalme A; Weiland O
Infect Dis (Lond); 2018 Mar; 50(3):175-192. PubMed ID: 29105519
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus bacteraemia associated with injected new psychoactive substances.
Griffith DJ; Mackintosh CL; Inverarity D
Epidemiol Infect; 2016 Apr; 144(6):1257-66. PubMed ID: 26548371
[TBL] [Abstract][Full Text] [Related]
8. Oral antibiotic therapy in people who inject drugs (PWID) with bacteraemia.
Martinez AE; Scheidegger C; Bättig V; Erb S
Swiss Med Wkly; 2020 Jun; 150():w20259. PubMed ID: 32564343
[TBL] [Abstract][Full Text] [Related]
9. High Perineal and Overall Frequency of Staphylococcus aureus in People Who Inject Drugs, Compared to Non-Injectors.
Dahlman D; Jalalvand F; Blomé MA; Håkansson A; Janson H; Quick S; Nilsson AC
Curr Microbiol; 2017 Feb; 74(2):159-167. PubMed ID: 27896481
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality of Serratia marcescens bacteraemia during the substance use epidemic.
Bloom R; Thakarar K; Rokas KE
Int J Antimicrob Agents; 2023 Oct; 62(4):106934. PubMed ID: 37500021
[TBL] [Abstract][Full Text] [Related]
11. Clinical and financial burden of spinal infections in people who inject drugs.
Ananda RA; Attwood LO; Lancaster R; Jacka D; Jhoomun T; Danks A; Woolley I
Intern Med J; 2022 Oct; 52(10):1741-1748. PubMed ID: 34028966
[TBL] [Abstract][Full Text] [Related]
12. Dalbavancin vs standard of care for Staphylococcus aureus bacteraemia in patients unable to receive outpatient parenteral antimicrobial therapy.
Frazier JD; Stoudenmire LL; Wagner JL; Thomas GM; Steele GM; Henao-Martínez AF; Franco-Paredes C; Chastain DB
Int J Antimicrob Agents; 2023 Jul; 62(1):106842. PubMed ID: 37160242
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus endocarditis associated with injecting new psychoactive substances.
Joshi SS; Henderson N; Griffith DJ; Henriksen PA; Denvir MA; Macsween KF; Mackintosh CL; Inverarity D
J R Coll Physicians Edinb; 2018 Dec; 48(4):304-310. PubMed ID: 30488883
[TBL] [Abstract][Full Text] [Related]
14. Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis.
Tan C; Shojaei E; Wiener J; Shah M; Koivu S; Silverman M
JAMA Netw Open; 2020 Aug; 3(8):e2012974. PubMed ID: 32785635
[TBL] [Abstract][Full Text] [Related]
15. Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors.
Ramadan MS; Bertolino L; Boccia F; Hamieh M; Peluso AM; Gallo R; Patauner F; De Santo LS; Carozza A; Zampino R; Durante-Mangoni E;
Intern Emerg Med; 2024 Mar; 19(2):455-464. PubMed ID: 38129537
[TBL] [Abstract][Full Text] [Related]
16. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital.
Asgeirsson H; Thalme A; Weiland O
Medicine (Baltimore); 2016 Dec; 95(49):e5617. PubMed ID: 27930590
[TBL] [Abstract][Full Text] [Related]
17. Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.
Holmes NE; Robinson JO; van Hal SJ; Munckhof WJ; Athan E; Korman TM; Cheng AC; Turnidge JD; Johnson PDR; Howden BP;
BMC Infect Dis; 2018 Mar; 18(1):107. PubMed ID: 29506483
[TBL] [Abstract][Full Text] [Related]
18. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
[TBL] [Abstract][Full Text] [Related]
19. Paediatric Staphylococcus aureus bacteraemia: A single-centre retrospective cohort.
Roediger JC; Outhred AC; Shadbolt B; Britton PN
J Paediatr Child Health; 2017 Feb; 53(2):180-186. PubMed ID: 27566273
[TBL] [Abstract][Full Text] [Related]
20. Impact of infectious disease consultation on patients with Staphylococcus aureus bacteremia at a Japanese tertiary hospital: A retrospective observational study.
Suzuki J; Sasahara T; Minami K; Morisawa Y; Yamada T
J Infect Chemother; 2020 Aug; 26(8):780-784. PubMed ID: 32423701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
